Citigroup »

Axsome Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.1M 102k 79.57
2023-09-30 $11M 158k 69.91
2023-03-31 $3.0M 48k 61.68
2022-12-31 $3.1M 41k 77.13
2022-09-30 $2.2M 48k 44.61
2021-12-31 $454k 12k 36.92
2021-03-31 $338k 6.0k 56.60
2020-12-31 $3.0M 37k 81.71
2020-09-30 $3.6M 51k 71.17
2020-06-30 $20M 239k 82.27
2020-03-31 $703k 12k 59.06
2019-12-31 $859k 8.3k 102.89
2019-09-30 $51k 2.5k 20.31
2019-06-30 $999 22 45.45
2019-03-31 $265k 19k 14.24
2017-06-30 $0 1 0.00
2017-03-31 $0 39 0.00
2016-12-31 $23k 3.4k 6.68
2016-09-30 $7.0k 912 7.68
2016-06-30 $8.0k 1.1k 7.14